R J Faull

Summary

Affiliation: South Australia
Country: Australia

Publications

  1. ncbi HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration
    R J Faull
    Renal Laboratory, Royal Adelaide Hospital, Adelaide, South Australia
    Kidney Int 59:614-24. 2001
  2. ncbi Managing bone parameters in dialysis patients: international guideline conflicts
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital and the Department of Medicine, University of Adelaide, South Australia, Australia
    Semin Dial 20:191-4. 2007
  3. ncbi Lymphoproliferative disease after renal transplantation in Australia and New Zealand
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia
    Transplantation 80:193-7. 2005
  4. ncbi Bad and good growth factors in the peritoneal cavity
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia
    Nephrology (Carlton) 10:234-9. 2005
  5. ncbi Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis
    K H Zarrinkalam
    Department of Renal Medicine, Royal Adelaide Hospital, South Australia, Australia
    Perit Dial Int 21:501-8. 2001
  6. ncbi BK transplant nephropathy successfully treated with cidofovir
    Lisa S Keller
    Department of Renal Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, SA 3000, Australia
    Nephrol Dial Transplant 18:1013-4. 2003
  7. ncbi Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients
    Stephanie E Reuter
    Sansom Institute, University of South Australia, Adelaide, SA, Australia
    Nephrol Dial Transplant 24:990-6. 2009
  8. ncbi Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
    Allan M Evans
    Centre for Pharmaceutical Research, School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Adelaide, South Australia, Australia
    Kidney Int 66:1527-34. 2004
  9. ncbi L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Stephanie E Reuter
    Sansom Institute, University of South Australia, and Department of Renal Medicine, Royal Adelaide Hospital, South Australia, Australia
    Nephrology (Carlton) 13:3-16. 2008
  10. ncbi Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
    Stephanie E Reuter
    Centre for Pharmaceutical Research, University of South Australia, North Terrace, Adelaide, SA 5000, Australia
    Ann Clin Biochem 42:387-93. 2005

Collaborators

  • Allan Evans
  • Kym M Bannister
  • G J Atkins
  • Shilpanjali Prasad
  • Lisa S Keller
  • Stephanie E Reuter
  • Mohammed O Kaisar
  • Lisa S Jeffs
  • Krystyna H Zarrinkalam
  • Cu T Lu
  • K H Zarrinkalam
  • Enzo Ranieri
  • Kumar Mahadevan
  • Jodie Nitschke
  • Frances Skilton
  • Gianfranco Fornasini
  • Donald H Chace
  • David I Watson
  • Tony J Elias
  • Jodie M Stanley
  • Julia Gray
  • Anthony R Clarkson
  • Noelynn Oliver
  • D I Leavesley
  • J M Stanley

Detail Information

Publications14

  1. ncbi HB-EGF is produced in the peritoneal cavity and enhances mesothelial cell adhesion and migration
    R J Faull
    Renal Laboratory, Royal Adelaide Hospital, Adelaide, South Australia
    Kidney Int 59:614-24. 2001
    ..Heparin-binding epidermal growth factor-like growth factor (HB-EGF) has an important role in wound repair and is also fibrogenic, and thus may be involved in these processes in the peritoneal cavity...
  2. ncbi Managing bone parameters in dialysis patients: international guideline conflicts
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital and the Department of Medicine, University of Adelaide, South Australia, Australia
    Semin Dial 20:191-4. 2007
    ..Readers of guidelines such as these need to be careful to interpret such recommendations in the context of the realities of their local clinical practice and availability of therapies...
  3. ncbi Lymphoproliferative disease after renal transplantation in Australia and New Zealand
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia
    Transplantation 80:193-7. 2005
    ..It is well documented that the risk of its development increases with the level of immunosuppression. Less is known about its incidence, prevalence, timing, and prognosis...
  4. ncbi Bad and good growth factors in the peritoneal cavity
    Randall J Faull
    Renal Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia
    Nephrology (Carlton) 10:234-9. 2005
    ....
  5. ncbi Expression of defensin antimicrobial peptides in the peritoneal cavity of patients on peritoneal dialysis
    K H Zarrinkalam
    Department of Renal Medicine, Royal Adelaide Hospital, South Australia, Australia
    Perit Dial Int 21:501-8. 2001
    ..Variable levels of expression of hbetaD-2 by mesothelial cells were seen, with evidence of regulation by cytokines and growth factors. This provides evidence for a previously unknown mechanism of innate immunity at that site...
  6. ncbi BK transplant nephropathy successfully treated with cidofovir
    Lisa S Keller
    Department of Renal Medicine, Royal Adelaide Hospital, North Terrace, Adelaide, SA 3000, Australia
    Nephrol Dial Transplant 18:1013-4. 2003
  7. ncbi Endogenous plasma carnitine pool composition and response to erythropoietin treatment in chronic haemodialysis patients
    Stephanie E Reuter
    Sansom Institute, University of South Australia, Adelaide, SA, Australia
    Nephrol Dial Transplant 24:990-6. 2009
    ..This study examined the relationship between endogenous carnitine pool composition and rHuEPO requirements in long-term haemodialysis patients...
  8. ncbi Impact of hemodialysis on endogenous plasma and muscle carnitine levels in patients with end-stage renal disease
    Allan M Evans
    Centre for Pharmaceutical Research, School of Pharmaceutical, Molecular and Biomedical Sciences, University of South Australia, Adelaide, South Australia, Australia
    Kidney Int 66:1527-34. 2004
    ..This study examined the relationship between duration of dialysis and plasma and skeletal muscle concentrations of L-carnitine and its esters in ESRD patients...
  9. ncbi L-carnitine supplementation in the dialysis population: are Australian patients missing out?
    Stephanie E Reuter
    Sansom Institute, University of South Australia, and Department of Renal Medicine, Royal Adelaide Hospital, South Australia, Australia
    Nephrology (Carlton) 13:3-16. 2008
    ....
  10. ncbi Impact of haemodialysis on individual endogenous plasma acylcarnitine concentrations in end-stage renal disease
    Stephanie E Reuter
    Centre for Pharmaceutical Research, University of South Australia, North Terrace, Adelaide, SA 5000, Australia
    Ann Clin Biochem 42:387-93. 2005
    ..Removal is significantly correlated to acyl chain length, most likely due to the increased molecular weight and lipophilicity that accompanies increased chain length...
  11. ncbi Primary presentation with metastatic merkel cell carcinoma in a renal transplant recipient
    Mohammed O Kaisar
    Renal Unit, Royal Adelaide Hospital, North Terrace, Adelaide, South Australia, Australia
    Nephrology (Carlton) 12:420-1. 2007
  12. ncbi Effect of pravastatin on markers of endothelial activation in dialysis patients
    Lisa S Jeffs
    Department of Renal Medicine, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    Nephrology (Carlton) 12:234-8. 2007
    ..The aim of this pilot study was to test the effect of pravastatin on serum levels of high-sensitivity CRP (hs-CRP), IL-6 and the soluble adhesion molecules sVCAM-1, sICAM-1 and sE-selectin in chronic dialysis patients...
  13. ncbi Laparoscopic placement of peritoneal dialysis catheters: 7 years experience
    Cu T Lu
    The University of Adelaide, Department of Surgery, Royal Adelaide Hospital, Adelaide, South Australia, Australia
    ANZ J Surg 73:109-11. 2003
    ..The majority of patients will dialyse successfully using this technique. Suturing the catheter tip into the pelvis is associated with a low rate of catheter migration...
  14. ncbi Connective tissue growth factor and its regulation in the peritoneal cavity of peritoneal dialysis patients
    Krystyna H Zarrinkalam
    Department of Renal Medicine, Royal Adelaide Hospital, Adelaide, South Australia
    Kidney Int 64:331-8. 2003
    ....